Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • tcw
    Junior Member
    • Jul 2014
    • 1

    Fail Lane :(

    Hi All
    I'm new in sequencing field, may ask some stupid questions. Hopefully get some suggestions on my troubles.
    And actually I only prepare the libraries and samples, the sequencing and kapa qPCR were done in the core facility. So I really am not familiar with sequencer running, but got the fail results from the core running but can not figure what is wrong.
    I have a set of sequencing running on HIseq2500 with 2 flow cells(2 plex, each plex contained 12 indexed samples). One plex pass through the sequencing with good cluster density and reads. But one plex failed which gave low cluster density (probably are all Phix clusters) and the limited reads it came out all aligned to Phix. It confused me is that before go into sequencing, we have those indexed samples running on qPCR and kapa qPCR to adjust the balance for all the samples to pool together. And kapa qPCR supposed gave us the quantification only PCR-competent DNA products which are indexed sequences. And there are not much differences between these two plex on kapa qPCR results. So I’m SO CONFUSED why one plex form clusters perfectly but the other totally fail, no any clusters and reads. One more question, I want to ask that we have 12 indexing sequeces in one plex. If one of the index didn’t go well, will it make the whole plex fail? We anyway prepare each sample library separately, only pool together when go on sequencer, kind of not possible 12 samples are all bad in one plex but all good in another plex accidently.
    thank you for any suggestions and comments.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 12:17 PM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Working...